Dr. Pamela Reilly Contag
Institution Name:
Total Awards:
1
Award Value:
$7,999,689
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | BioEclipse Therapeutics INC. | PHASE 1, OPEN LABEL, DOSE-ESCALATION STUDY OF CRX100 IN PATIENTS WITH ADVANCED SOLID TUMORS | $7,999,689 |
| Total: $7,999,689.00 |